Faculty Information - YAGISAWA Takafumi

（Last updated : 2024-04-18 15:09:53）

YAGISAWA Takafumi
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Department of Urology

Position Assistant Professor

■ Published papers

1.	Original article	The medical cost and outcome of desensitization protocol in kidney transplantation recipients with high immunological risks 2024/01/09
2.	Original article	En bloc kidney transplantation from pediatric donors to teenage recipients: Two case reports. 2023/12/27
3.	Case report	Kidney transplantation after multiple urinary tract conversion with an ileal conduit: A case report. 2023/05/14
4.	Original article	Pregnancy complications and impact on kidney allograft after kidney transplantation in IgA nephropathy. 2023/05/04
5.	Original article	Surgical outcomes of robot-assisted laparoscopic partial nephrectomy for cystic renal cell carcinoma. 2022/06
6.	Original article	Recipient myeloperoxidase-producing cells regulate antibody-mediated acute versus chronic kidney allograft rejection. 2021/07/08
7.	Original article	Developmental loss, but not pharmacological suppression, of renal carbonic anhydrase 2 results in pyelonephritis susceptibility. 2020/06
8.	Original article	In the absence of natural killer cell activation donor-specific antibody ediates chronic, but not acute, kidney allograft rejection. 2019/02
9.	Original article	Effect of the timing of best tumor shrinkage on survival of patients with metastatic renal cell carcinoma who received first-line tyrosine kinase inhibitor therapy. 2017/02
10.	Original article	Novel approach for bladder cancer treatment using sulfoquinovosylacylpropanediol as a radiosensitizer. 2016/03
11.	Original article	Arteriosclerosis in zero-time biopsy is a risk factor for tacrolimus-induced chronic nephrotoxicity. 2015/07
12.	Case report	Combination of molecular targeted therapy and surgery for a patient with metastatic renal cell carcinoma with a poor prognosis. 2015/07
13.	Other	The phenotype of repopulating B cell after rituximab therapy in kidney transplant patients. 2014/11
14.	Original article	A case of focal segmental glomerulosclerosis diagnosed as the original underlying disease after cadaveric renal transplantation 2012/09
Display 5 items
Display all(14)

■ Academic conference presentation

1.	Assessing long-term complications of kidney transplantation without intraoperative ureteral dj stent: A single-center experience. 2023/06/06
2.	Elderly living kidney transplant donors and their renal prognosis. 2023/06/06
3.	The outcome of kidney transplantation after cancer treatment in the patient with high estimated cure rate. 2023/06/06
4.	Donor-derived cell-free DNA analysis is capable of detecting antibody-mediated rejection in one-year biopsy of living kidney transplantation. 2023/06/05
5.	Effects and side effects of desensitization therapy in flow cytometry crossmatch-negative, Low-dose donor-specific antibody-positive renal transplant recipients. 2023/06/04
6.	Impact of current desensitization protocols and surgical outcomes in ABO-incompatible kidney transplant recipients: A Japanese single-center experience. 2023/06/04
7.	The long-term renal outcome and pregnancy complications with kidney transplantation of IgA nephropathy. 2023/06/03
8.	Postoperative management of renal transplantation: what you need to know. 2023/04/21
9.	Donor-derived cell-free DNA analysis is capable of detecting antibody-mediated rejection in one-year biopsy of kidney allograft. 2023/04/20
10.	Cost effectiveness of kidney transplantation in high-immunological risk patients in a Japan cohort. 2022/11/26
11.	Influence of HLA epitope mismatch on the kidney allograft after transplantation. 2022/11/26
12.	Outcomes of ABO-compatible living kidney transplantation recipients with low immunological risk. 2022/11/26
13.	Outcomes of treatments for acute antibody-mediated rejection after kidney transplantation. 2022/11/26
14.	A case of kidney transplantation after multiple urinary tract conversion with an ileal conduit. 2022/11/25
15.	En bloc kidney transplant from pediatric donors to teenage recipients: A single-center experience. 2022/11/25
16.	Evaluation of cases of cytomegalovirus infection after renal transplantation at our department. 2022/11/25
17.	Preconception care and pregnancy complications after kidney transplantation: A single-center study. 2022/11/25
18.	Recurrence of cancer in 188 kidney transplant recipients. 2022/11/25
19.	Antibody responses to BNT162b2 booster in kidney transplant recipients vacci‐nated twice. 2022/10/24
20.	Antibody response to sars-CoV-2 vaccine among kidney transplant recipients: A retrospective cohort study. 2022/06/06
21.	Two times or more double-filtration plasmapheresis increases the risk of bleeding during kidney transplantation. 2022/06/05
22.	Impact of rituximab induction therapy on donor-specific anti-HLA antibodies in abo-compatible kidney transplant recipients. 2021/06/04
23.	The evaluation of living-related kidney transplantation donors in autosomal-dominant polycystic kidney disease. 2021/06/04
24.	Donor-specfic antibody mediates chronic, but not acute, kidney allograft rejection in the absence of natural killer cells. 2018/06/05
25.	The degree of NK cell activation determines the ability of donor-specific antibodies to mediate acute vs. chronic rejection of kidney allografts. 2017/05/01
26.	The degree of NK cell activation determines the ability of donor-specific antibodies to mediate acute vs. chronic rejection of kidney allografts. 2017/04/07
27.	Allograft TLR4 receptor signaling induces specific early inflammatory events in promotes allografts subjected to prolonged cold ischemic storage. 2016/06/13
28.	The relationship between the timing of maximum tumor shrinkage during 1st-line targeted therapy and overall survival of patients with metastatic renal cell carcinoma. 2015/05/18
29.	Excellent outcomes of prophylactic rituximab administration with plasmapheresis in kidney transplant recipients with focal segmental glomerulosclerosis. 2015/05/02
30.	ERECTILE DYSFUNCTION RISK FACTORS IN PATIENTS WITH SEVERE OBSTRUCTIVE SLEEP APNEA SYNDROME AND IDENTIFYING CPAP RESPONSE PREDICTORS 2014/09/22
31.	Histological findings at zero-time biopsy have an important role in the diagnosis of chronic tacrolimus nephrotoxicity 2013/11/08
32.	RESUL OF TRANSURETHRAL URETEROLITHOTRIPSY(TUL) AND CLINICAL CHARACTERISTICS OF ACUTE PYELONEPHRITIS FOLLWING TUL 2013/10/25
33.	A case of recurrent FSGS diagnosed as underlying disease following deceased donor kidney transplantation and a review of recurrent FSGS cases after transplantation at our institution 2013/09/04
34.	Evaluation of the association between histological findings of arteriosclerosis in zero-time biopsy and tacrolimus-induced nephrotoxicity 2013/09/04
35.	Risk Factor for Erectile Dysfunction in Patients with SAS and Predictor Identifying Responders to CPAP 2013/06/27
36.	Arteriosclerosis in Histological Evaluations Using Zero-Time Biopsy Is a Risk Factor for Tacrolimus-Induced Nephrotoxicity 2013/05/19
37.	Usefulness of temporary inferior vena cava filter in preventing intraoperative pulmonary embolism for patients with renal cell carcinoma extending into inferior vena cava thrombus 2013/05/07
38.	Impact of Right-sided Nephrectomy on Long-term Outcomes in Retroperitoneoscopic Live Donor Nephrectomy 2012/04/23
Display 5 items
Display all(38)

■ Education

1.	2015/06～2018/03	Lerner Research Institute, Cleveland Clinic, Studying abroad
2.	2011/04～2014/12	〔Doctoral course〕, Graduate School, Division of Medicine, Tokyo Women's Medical University, Completed,
3.	2003/04～2009/03	Faculty of Medicine, Saitama Medical University, Graduated